Irena Mlinarič-Raščan

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 4

Top Topics

Allogeneic Hematopoietic Stem Cell Transplantation

End Stage Renal Disease

Ejection Fraction

Top Venues

Acta pharmaceutica (Zagreb, Croatia)

Cell death & disease

This page only lists publications with an associated author ORCID identifier.

Publications

Flaka Pasha, Dunja Urbančič, Rufadie Maxhuni, Shaip Krasniqi, Violeta Grajçevci Uka, Irena Mlinarič-Raščan
Prevalence and Treatment Outcomes of Childhood Acute Lymphoblastic Leukemia in Kosovo. Cancers 16 (11) (2024)
Dunja Urbančič, Flaka Pasha, Alenka Šmid, Irena Mlinarič-Raščan
Personalization of thiopurine therapy: Current recommendations and future perspectives. Acta pharmaceutica (Zagreb, Croatia) 74 (3) (2024)
Flaka Pasha, Dunja Urbančič, Rufadie Maxhuni, Shaip Krasniqi, Violeta Grajçevci Uka, Irena Mlinarič-Raščan
Prevalence and Treatment Outcomes of Childhood Acute Lymphoblastic Leukemia in Kosovo. Cancers 16 (11) (2024)
Damjan Avsec, Marja Škrlj Miklavčič, Tilen Burnik, Maša Kandušer, Maruša Bizjak, Helena Podgornik, Irena Mlinarič-Raščan
Inhibition of p38 MAPK or immunoproteasome overcomes resistance of chronic lymphocytic leukemia cells to Bcl-2 antagonist venetoclax. Cell death & disease 13 (10) (2022)